🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
MTBVAC at four dose levels: 5 x 10\^3 CFU, 5 x 10\^4 CFU, 5 x 10\^5 CFU, an...
Status
Completed
Location
SATVI: Worcester
Start Date
2018-05-14
Trial ID
NCT02933281
The objective of this project is to demonstrate safety, immunogenicity and ...
Status
Recruiting
Location
South African Tuberculosis Initiative, Brewelskloof Hospital
Start Date
2022-10-17
Trial ID
NCT04975178
Randomized, controlled, double blind clinical trial in 2 stages (adult stag...
Status
Completed
Location
South African Tuberculosis Vaccine Initiative, Brewelskloof Hospital
Start Date
2015-09
Trial ID
NCT02729571
A Phase 2b, double-blind, randomized, placebo-controlled study to evaluate ...
Status
Recruiting
Location
Victoria Biomedical Research Institute
Start Date
2025-02-19
Trial ID
NCT06272812
A Phase 2a dose-defining study of MTBVAC to evaluate the safety, reactogeni...
Status
Completed
Location
SATVI: Worcester
Start Date
2019-02-12
Trial ID
NCT03536117
A cross-sectional childhood M. tuberculosis infection survey of age-specifi...
Status
Completed
Location
Biomedical Research Center EPLS
Start Date
2018-07-27
Trial ID
NCT03767946
Treatments Being Tested
Phase II trial to establish the safety, reactogenicity, and immunogenicity ...
Status
Active Not Recruiting
Location
Guru Teg Bahadur Hospital
Start Date
2025-03-27
Trial ID
NCT06997367
The purpose of this study is to test the safety and immunogenicity of MTBVA...
Status
Completed
Location
Centre Hospitalier Universitaire Vaudois
Start Date
2013-01
Trial ID
NCT02013245
Treatments Being Tested
The purpose of this study is to evaluate the safety and immunogenicity of M...
Status
Recruiting
Location
Soweto - Gauteng
Start Date
2024-01-30
Trial ID
NCT05947890
An Open-labelled, Phase I Clinical Trial to Assess the Safety, Reactogenici...
Status
Completed
Location
NIMS, Hyderabad
Start Date
2024-01-19
Trial ID
NCT06438978
Treatments Being Tested